Mind Medicine Australia Clinic and Centre of Excellence in Melbourne is a leading centre for the treatment of Post-Traumatic Stress Disorder and Treatment Resistant Depression.
We partner with highly trained and skilled clinical teams to provide evidence-based treatments, which are at the cutting edge of mental healthcare and are designed to help people who have tried other treatments without sufficient success.
New Treatments
At Mind Medicine Australia Clinic, we know that lasting change takes courage, compassion, and commitment.
When you engage with our outstanding, caring and professional team you will be commencing a transformative therapeutic journey. If you're eligible, we will accompany you closely through a tailored model of care, supported by a multidisciplinary team of highly qualified, skilled, and experienced clinicians.
The innovative treatments you will receive at Mind Medicine Clinic are not a standalone pharmaceutical treatment, nor are they microdosing. They are a specialised and comprehensive therapeutic approach which can lead to effective and lasting healing.
Our aim is to deliver the best possible outcomes through a comprehensive patient-centric approach.
Express interest in treatment
Our Core Priorities
- Safe and effective outcomes that promote lasting positive change for our clients through innovative and tailored care.
- Highly qualified and trained clinical staff working within evidence-based protocols in a supportive environment.
- Improved accessibility though economic evaluation, subsidies, and the most affordable medicine and therapeutic costs available.
The Mind Medicine Australia Clinic (MMAC) represents an important step forward in MMA's strategy to integrate psychedelic-assisted therapies into Australia's mental healthcare system.
With the TGA's World first decision to permit the use of MDMA to treat PTSD and psilocybin to treat treatment-resistant depression, this clinic will function as a Centre of Excellence in the emerging psychedelic field. It will provide clinical services and demonstrate MMA's ability to rollout clinical sites with a strict adherence to governance and medical oversight, low-cost medicine supply and marketing support to a network of aligned Authorised Prescribers across Australia. The combination of these factors will ensure a robust quality of care model for patients.
Alongside the clinical services, the clinic will also provide practical training opportunities for graduates of MMA's world-leading Certificate in Psychedelic-Assisted Therapies course (CPAT).
About Mind Medicine Australia
Mind Medicine Australia is Australia's leading not-for-profit organization supporting the clinical adoption of psychedelic-assisted therapies involving medicinal psilocybin and MDMA. In 2023, Mind Medicine Australia successfully led the world's first regulatory rescheduling of psilocybin and MDMA for controlled clinical use in the treatment of PTSD and treatment-resistant depression.
About Psychennex
Psychennex is an Australian subsidiary of NASDAQ listed Incannex Healthcare Ltd. Through it's clinical trials in the use of psilocybin-assisted therapy for Generalised Anxiety Disorder, it has become an Australian leader in the psychedelic-assisted therapy space.
